Evidence map›Paper›PMID 38221889›Full record

ArticleEpigenomics2024

Matched analysis of detailed peripheral blood and tumor immune microenvironment profiles in bladder cancer.

Ji-Qing Chen, Lucas A Salas, John K Wiencke, Devin C Koestler, Annette M Molinaro, Angeline S Andrew, John D Seigne, Margaret R Karagas, Karl T Kelsey, Brock C Christensen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epigenomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Prediction of CD8Scientific reports · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ji-Qing ChenDepartment of Epidemiology, Geisel School of Medicine, Dartmouth College, Lebanon, NH 03766, USA.ORCID 0000-0002-1598-8811
Lucas A SalasDepartment of Epidemiology, Geisel School of Medicine, Dartmouth College, Lebanon, NH 03766, USA.ORCID 0000-0002-2279-4097
John K WienckeDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0001-7101-6489
Devin C KoestlerDepartment of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, KS 66160, USA.ORCID 0000-0002-0598-0146
Annette M MolinaroDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0002-9854-7404
Angeline S AndrewDepartment of Neurology, Geisel School of Medicine, Dartmouth College, Lebanon, NH 03766, USA.ORCID 0000-0002-3731-5300
John D SeigneDepartment of Surgery, Section of Urology, Geisel School of Medicine, Dartmouth College, Lebanon, NH 03766, USA.ORCID 0000-0002-7057-8727
Margaret R KaragasDepartment of Epidemiology, Geisel School of Medicine, Dartmouth College, Lebanon, NH 03766, USA.ORCID 0000-0002-6398-7362
Karl T KelseyDepartments of Epidemiology & Pathology & Laboratory Medicine, Brown University, Providence, RI 02912, USA.ORCID 0000-0002-2302-1600
Brock C ChristensenDepartment of Epidemiology, Geisel School of Medicine, Dartmouth College, Lebanon, NH 03766, USA.ORCID 0000-0003-3022-426X

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
Tissue CoreP50CA097257 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joseph F Costello · 2002 to 2026
$57.4M
Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ROY A. JENSEN · 2012 to 2026
$40.1M
Relation Between In-utero Vitamin D and Immune Function in Early Childhood P20GM104416 · NIGMS · DARTMOUTH COLLEGE · PI SALAS DIAZ, LUCAS A · 2013 to 2022
$23.7M
Using Integrated Omics to Identify Dysfunctional Genetic Mechanisms Influencing Schizophrenia and Sleep DisturbancesP20GM130423 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Diane E Mahoney · 2019 to 2026
$21.5M
NONMELANOMA SKIN CANCER IN NEW HAMPSHIRER01CA057494 · NCI · DARTMOUTH COLLEGE · PI KARAGAS, MARGARET RITA · 1993 to 2015
$10.9M
Immune epigenetic biomarkers of survival in glioma epidemiologyR01CA207360 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WIENCKE, JOHN K. · 2017 to 2021
$3.8M
DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to ImmunotherapyR01CA253976 · NCI · BROWN UNIVERSITY · PI CHRISTENSEN, BROCK C, KELSEY, KARL TIMOTHY · 2021 to 2025
$3.3M
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomesR01CA216265 · NCI · DARTMOUTH COLLEGE · PI CHRISTENSEN, BROCK CLARKE · 2017 to 2021
$2.9M
NCI NIH HHS P30 CA023108NCI NIH HHS P30 CA168524NCI NIH HHS P50 CA097257NCI NIH HHS R01 CA057494NCI NIH HHS R01 CA207360NCI NIH HHS R01 CA216265NCI NIH HHS R01 CA253976NIGMS NIH HHS P20 GM104416NIGMS NIH HHS P20 GM130423NIH HHS P20GM104416, P50CA097257, R01CA057494, R01CA207360, R01CA216265, R01CA253976
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Tumor MicroenvironmentUrinary Bladder NeoplasmsCluster AnalysisDNA MethylationHumansPrognosisProtein Processing, Post-Translationalbladder cancercirculating immune profilesDNA methylationimmune profilesmethylation cytometrytumor microenvironment

Identifiers

PMID38221889
PMCPMC10804212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.